VOYA Investment Management
KLRS

VOYA Investment Management’s Kalaris Therapeutics KLRS Stock Holding History

VOYA Investment Management’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-935
Closed -$14.6K – 2900
2023
Q4 		$14.6K Hold
935
– – ﹤0.01% 2895
2023
Q3 		$46.2K Buy
935
+193
+26% +$13.2K ﹤0.01% 2862
2023
Q2 		$58K Buy
742
+183
+33% +$17.4K ﹤0.01% 2887
2023
Q1 		$50.6K Hold
559
– – ﹤0.01% 2800
2022
Q4 		$65.9K Hold
559
– – ﹤0.01% 2817
2022
Q3 		$101K Buy
559
+64
+13% +$9.97K ﹤0.01% 2776
2022
Q2 		$44K Hold
495
– – ﹤0.01% 2755
2022
Q1 		$77K Hold
495
– – ﹤0.01% 2551
2021
Q4 		$147K Sell
495
-11
-2% -$5.1K ﹤0.01% 2593
2021
Q3 		$292K Sell
506
-22
-4% -$10.2K ﹤0.01% 2359
2021
Q2 		$240K Sell
528
-27
-5% -$13.9K ﹤0.01% 2498
2021
Q1 		$299K Buy
555
+218
+65% +$183K ﹤0.01% 2317
2020
Q4 		$298K Buy
+337
New +$259K ﹤0.01% 2200

Other funds holding KLRS

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VOYA Investment Management's KLRS Position: Q1 2024 in Review

VOYA Investment Management sold out of Kalaris Therapeutics (KLRS) in Q1 2024, closing a stake of 935 shares — an estimated $14.6K sold.

VOYA Investment Management first reported a position in KLRS in Q4 2020 and held it in 13 quarters. The position peaked at $299K in Q1 2021. 76 funds tracked by Wall St. Rank hold KLRS as of Q1 2024.

  • VOYA Investment Management reported no remaining Kalaris Therapeutics position as of Q1 2024 after selling out during the quarter.
  • VOYA Investment Management sold 935 Kalaris Therapeutics shares in Q1 2024, an estimated $14.6K.
  • VOYA Investment Management first reported a position in Kalaris Therapeutics in Q4 2020 and held it in 13 quarters.
  • VOYA Investment Management's Kalaris Therapeutics position peaked at $299K in Q1 2021.
  • 76 funds tracked by Wall St. Rank held Kalaris Therapeutics as of Q1 2024.

Based on VOYA Investment Management's 13F filing for Q1 2024, filed 15 May 2024.